GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cohance Lifesciences COHANCE.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

443.65

+2.33%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹22.69bn

FY2019FY2026

Net income

₹1.79bn

FY2019FY2026

Free cash flow

₹1.35bn

FY2019FY2026

Shareholders' equity

₹39.11bn

FY2019FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue₹22.69bn₹11.98bn₹10.51bn₹13.40bn₹13.20bn₹10.10bn₹8.34bn₹9.07bn
Gross profit₹9.11bn₹8.22bn₹6.80bn₹7.52bn₹7.46bn₹5.73bn₹5.00bn₹5.34bn
Research and development———₹85.9m₹103.5m₹110.6m₹141.3m—
Operating income₹2.40bn₹5.66bn₹5.40bn₹6.30bn₹6.42bn₹4.83bn₹4.16bn₹4.53bn
Net income₹1.79bn₹2.68bn₹3.00bn₹4.11bn₹4.54bn₹3.62bn₹3.17bn₹2.62bn
Diluted earnings per share4.6810.4711.7016.1917.8214.2412.4410.28

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets₹57.30bn₹30.32bn₹22.54bn₹19.66bn₹18.30bn₹14.74bn₹11.73bn₹7.83bn
Cash and short-term investments₹3.26bn₹2.90bn₹8.21bn₹4.84bn₹5.26bn₹1.88bn₹423.7m₹179.7m
Total liabilities₹16.96bn₹11.91bn₹2.03bn₹2.31bn₹3.02bn₹2.94bn₹3.28bn₹1.93bn
Debt₹4.00bn₹2.79bn₹650.0m₹703.4m₹971.3m₹1.43bn₹1.86bn₹827.9m
Shareholders' equity₹39.11bn₹16.97bn₹20.51bn₹17.35bn₹15.27bn₹11.81bn₹8.45bn₹5.90bn
Shares outstanding383m256m257m254m255m254m255m255m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations₹3.55bn₹2.88bn₹3.58bn₹4.51bn₹3.30bn₹3.83bn₹4.16bn₹504.0m
Capital spending−₹2.20bn−₹1.56bn−₹517.9m−₹2.86bn−₹751.9m−₹1.11bn−₹994.1m−₹567.9m
Free cash flow₹1.35bn₹1.32bn₹3.07bn₹1.65bn₹2.55bn₹2.73bn₹3.17bn−₹63.8m
Dividends paid———−₹2.04bn−₹1.02bn−₹254.6m−₹767.2m−₹230.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹4.22bn₹6.19bn₹5.45bn₹5.56bn₹5.49bn₹4.02bn₹3.07bn₹2.58bn
Gross profit₹1.19bn₹2.24bn₹3.86bn₹4.14bn₹4.01bn₹1.98bn₹2.52bn₹2.06bn
Operating income−₹483.8m₹474.5m₹484.1m₹769.3m₹2.68bn₹771.5m₹1.88bn₹1.54bn
Net income−₹241.2m₹195.5m₹367.2m₹740.8m₹488.8m₹420.1m₹828.8m₹822.1m
Diluted earnings per share-0.630.511.442.901.911.643.233.20
Cash from operations———₹2.61bn————
Capital spending———−₹897.0m————
Free cash flow———₹1.71bn————
Total assets₹51.92bn₹57.30bn—₹55.68bn—₹30.32bn—₹25.06bn
Cash and short-term investments₹4.59bn₹3.26bn₹4.00bn₹4.03bn₹2.80bn₹2.90bn₹6.56bn₹6.56bn
Debt—₹1.95bn—₹2.45bn—₹1.10bn—₹159.4m
Shareholders' equity₹38.95bn₹39.11bn₹39.25bn₹37.88bn₹18.41bn₹16.97bn₹20.28bn₹19.78bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue19.2%17.6%—
Operating income-27.6%-13.1%—
Net income-24.2%-13.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin50.0%54.0%54.8%—
Operating margin23.2%33.7%37.9%—
Net margin12.9%19.8%24.1%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings97.050.597.344.627.834.636.4
Price to sales7.711.327.813.79.612.413.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 9 Sept 2022.

FY2023FY2022FY2021
Paid in the year6.003.001.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.